Trexquant Investment’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
DTC
BBA
Trexquant Investment's DSGN Position: Q3 2026 in Review
Trexquant Investment increased its Design Therapeutics (DSGN) stake by 58% in Q3 2026, buying an estimated $225K and bringing the position to 44,449 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1632.
Trexquant Investment first reported a position in DSGN in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.25M in Q1 2026. 142 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Trexquant Investment held 44,449 shares of Design Therapeutics worth $559K as of Q3 2026.
- Trexquant Investment bought 16,299 Design Therapeutics shares in Q3 2026, an estimated $225K.
- Design Therapeutics made up ﹤0.01% of Trexquant Investment's portfolio in Q3 2026, its #1632 holding.
- Trexquant Investment first reported a position in Design Therapeutics in Q3 2022 and has held it in 7 quarters since.
- Trexquant Investment's Design Therapeutics position peaked at $1.25M in Q1 2026.
- 142 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.